Urgent.News

What's breaking now, across thousands of outlets.

Finance & Markets

8x8 earnings beat by $0.04, revenue topped estimates

8x8 earnings beat by $0.04, revenue topped estimates

Vertex A, a company listed on NASDAQ under the ticker VERX, has reported stronger-than-expected results for the third quarter. The company's earnings per share (EPS) reached $0.26, surpassing the analysts' estimate of $0.22 by $0.04. The revenue for the quarter amounted to $213.3 million, outpacing the consensus estimate of $209.69 million.

Looking ahead, Vertex A anticipates revenue of $215.00 million to $217.00 million for Q4 2026, which is slightly below the analyst consensus of $217.00 million. For the full fiscal year 2026, Vertex A projects revenue of $828.90 million to $830.90 million, again slightly below the consensus estimate of $827.20 million.

At the close of the trading day, Vertex A's stock price settled at $15.92. Over the past three months, the stock price has experienced a significant 33.33% increase, while over the past year, it has declined by 20.72%. The company has garnered 8 positive EPS revisions and just 1 negative EPS revision in the last 90 days, indicating a generally positive market sentiment.

InvestingPro has rated Vertex A's financial health as "good performance." Investors can explore Vertex A's recent earnings performance and financials through InvestingPro's comprehensive database. To stay informed about upcoming earnings reports, investors can refer to Investing.com's earnings calendar.

Written by urgent.news from Investing.com's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.

This story

This is one outlet's version. Read the fullest account.

Read the original at investing.com →

More in Finance & Markets

Bausch + Lomb: 3 Key Takeaways for Long-Term Investors

Premium product adoption is lifting margins faster than revenue growth, a sign of pricing power in a competitive market.

  • Bausch + Lomb reported 8% revenue growth to $1.375 billion in Q3 2026
  • Premium IOLs surged 70% quarter-over-quarter, boosting product mix
  • Management expects full-year revenue and profit targets to rise

More from Thursday 5 November →